Menu
Search
|

Menu

Close
X

Beijing Tiantan Biological Products Corp Ltd 600161.SS (Shanghai Stock Exchange)

22.15 CNY
-0.02 (-0.09%)
As of 7:00 AM GMT
chart
Previous Close 22.17
Open 22.12
Volume 4,278,779
3m Avg Volume 4,605,171
Today’s High 22.36
Today’s Low 21.88
52 Week High 29.08
52 Week Low 16.80
Shares Outstanding (mil) 670.11
Market Capitalization (mil) 22,026.41
Forward P/E 19.84
Dividend (Yield %) 0.23 ( 0.70 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.00 Mean rating from 2 analysts

KEY STATS

Revenue (mm, CNY)
FY18
2,057
FY17
2,078
FY16
2,138
FY15
1,618
EPS (CNY)
FY18
0.455
FY17
1.304
FY16
0.329
FY15
0.011
*Note: Units in Millions of Renminbi
**Note: Units in Renminbi

KEY RATIOS

Price to Earnings (TTM)
vs sector
19.84
33.64
Price to Sales (TTM)
vs sector
10.20
5.95
Price to Book (MRQ)
vs sector
7.85
4.89
Price to Cash Flow (TTM)
vs sector
--
22.90
Total Debt to Equity (MRQ)
vs sector
7.13
17.74
LT Debt to Equity (MRQ)
vs sector
7.13
13.15
Return on Investment (TTM)
vs sector
32.86
14.22
Return on Equity (TTM)
vs sector
45.83
15.99

EXECUTIVE LEADERSHIP

Xiaoming Yang
Chairman of the Board, Since 2010
Salary: --
Bonus: --
Yi Zhang
Chief Financial Officer, Deputy General Manager, Since 2017
Salary: --
Bonus: --
Daoxing Fu
General Manager, Since 2017
Salary: --
Bonus: --
Bainian Fu
Deputy General Manager, Since 2012
Salary: --
Bonus: --
Hongji Xu
Deputy General Manager, Since 2011
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Pharmaceuticals
Address:

No. 4
Sanjianfang Nanli, Chaoyang Dist
BEIJING   BEJ   100024

Phone: +8610.65434018

BEIJING TIANTAN BIOLOGICAL PRODUCTS CORPORATION LIMITED is a China-based company principally engaged in the biopharmaceutical businesses. The Company’s primary products include preventive products, blood products and other biological products, such as the influenza A (H1N1) vaccines (split, inactivated),hepatitis B vaccines, poliomyelitis vaccines, measles-mump-rubella (MMR) vaccines, encephalitis B vaccines, influenza vaccinations, bacterial vaccines, human serum albumin (HSA) and intravenous immunoglobulin (IVIG), among others. The Company mainly distributes its products within domestic markets and to Hong Kong markets.

SPONSORED STORIES